Linvoseltamab
Regeneron
['mmsm']
aa16: orr: 71%, vgpr and better: 60%. mpfs: nr for 200 mg while for it was 8 months for 50 mg #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter